2
M. Fitzgerald's Nurse Practitioner Questions
& Answers 100% Verified.
Active immunity - ✔✔✔resistance developed response to an antigen
Which is the most cost-effective form of prevention in healthcare? -
✔✔✔Primary prevention
When a critical portion of the population is immunized against a contagious
disease, most members of the group, even the unimmunized, are protected
against that disease because there is less opportunity for an outbreak, this is
defined as? - ✔✔✔Community immunity
Primary prevention - ✔✔✔Efforts to prevent an injury or illness from ever
occurring. Education, counseling, immunizations
Active immunization - ✔✔✔administration of antigens so patient actively
mounts a protective immune response
Passive immunity - ✔✔✔person receives sect antibodies, usually after the
administration of immune globulin (IG), after exposure to an infective agent-
Temporary immunity
passing of antibodies from mother to fetus
Secondary prevention - ✔✔✔-focuses on early identification of individuals or
communities experiencing illness
-examples: communicable disease screening, early detection diabetes;
screening for HTN
Tertiary prevention - ✔✔✔minimize disease associated complications and
negative health effects of the conditions
®™ pg. 1
, 2
Examples: medications/lifestyle modifications to normalize blood glucose
What is the role of zanamivir (Ralenza) and oseltamivir (Tamiflu) in the
treatment of influenza? - ✔✔✔Initiation of therapy early in acute influenza
illness can help minimize the severity of disease when the illness is causes
by a nonresistant viral strain.
When advising a patent about the influenza nasal spray vaccine, the NP
considers the following - ✔✔✔it contains live, attenuated virus
The most common mode of influenza virus transmission is via: -
✔✔✔respiratory droplet
In an immunocompetent adult, the length of incubation for the influenza
virus is on average? - ✔✔✔1-4 days
Signs and symptoms of uncomplicated influenza infection - ✔✔✔fevere,
mylagia, HA, malaise, nonproductive cough, sore throat, rhinitis typically
resolves within 1 weeks
Adult patients with influenza are infectious for how long? - ✔✔✔1 day before
symptoms- 5 days after onset of illness
Children up to 10 days
Immunocompromised infectious up to 3 weeks
Children younger than 9 should who are receiving their initial influenza
immunization should receive how many doses? - ✔✔✔2 separated by 4 or
more weeks.
Which is true of the MMR vaccine? - ✔✔✔Live (attenuated) virus
®™ pg. 2
, 2
Two doses given at least 1 month apart are recommended for adults who
have not been previously immunized
Discouraged during pregnancy
Pneumococcal disease is caused by - ✔✔✔Gram positive diplococcus
streptococcus pneumoniae
Average risk for pneumococcal vaccination - ✔✔✔<65 years of age without
chronic medical condition
no vaccination needed
Increased risk for pneumococcal vaccination - ✔✔✔>19 and <65 years of
age immunocompetent
Cigarette smokers or chronic conditions
(DM, COPD, CV disease, liver, kidney)
Should receive PPSV23 and repeat after 5 years
Highest risk for pneumococcal vaccination - ✔✔✔>65 years of age or
immunocompromised
>65 receive PCV13 followed by PPSV23 1 year later
Younger patients PCV13 followed by PPSV23 8 in weeks
HIV diagnoses patients and pneumococcal vaccination considerations -
✔✔✔100 times more at risk
receive vaccination as soon as possible
PCV13 followed by PPSV23 8 wks later
Second PPSV23 after 5 years, third dose after 65 y.o.
®™ pg. 3
M. Fitzgerald's Nurse Practitioner Questions
& Answers 100% Verified.
Active immunity - ✔✔✔resistance developed response to an antigen
Which is the most cost-effective form of prevention in healthcare? -
✔✔✔Primary prevention
When a critical portion of the population is immunized against a contagious
disease, most members of the group, even the unimmunized, are protected
against that disease because there is less opportunity for an outbreak, this is
defined as? - ✔✔✔Community immunity
Primary prevention - ✔✔✔Efforts to prevent an injury or illness from ever
occurring. Education, counseling, immunizations
Active immunization - ✔✔✔administration of antigens so patient actively
mounts a protective immune response
Passive immunity - ✔✔✔person receives sect antibodies, usually after the
administration of immune globulin (IG), after exposure to an infective agent-
Temporary immunity
passing of antibodies from mother to fetus
Secondary prevention - ✔✔✔-focuses on early identification of individuals or
communities experiencing illness
-examples: communicable disease screening, early detection diabetes;
screening for HTN
Tertiary prevention - ✔✔✔minimize disease associated complications and
negative health effects of the conditions
®™ pg. 1
, 2
Examples: medications/lifestyle modifications to normalize blood glucose
What is the role of zanamivir (Ralenza) and oseltamivir (Tamiflu) in the
treatment of influenza? - ✔✔✔Initiation of therapy early in acute influenza
illness can help minimize the severity of disease when the illness is causes
by a nonresistant viral strain.
When advising a patent about the influenza nasal spray vaccine, the NP
considers the following - ✔✔✔it contains live, attenuated virus
The most common mode of influenza virus transmission is via: -
✔✔✔respiratory droplet
In an immunocompetent adult, the length of incubation for the influenza
virus is on average? - ✔✔✔1-4 days
Signs and symptoms of uncomplicated influenza infection - ✔✔✔fevere,
mylagia, HA, malaise, nonproductive cough, sore throat, rhinitis typically
resolves within 1 weeks
Adult patients with influenza are infectious for how long? - ✔✔✔1 day before
symptoms- 5 days after onset of illness
Children up to 10 days
Immunocompromised infectious up to 3 weeks
Children younger than 9 should who are receiving their initial influenza
immunization should receive how many doses? - ✔✔✔2 separated by 4 or
more weeks.
Which is true of the MMR vaccine? - ✔✔✔Live (attenuated) virus
®™ pg. 2
, 2
Two doses given at least 1 month apart are recommended for adults who
have not been previously immunized
Discouraged during pregnancy
Pneumococcal disease is caused by - ✔✔✔Gram positive diplococcus
streptococcus pneumoniae
Average risk for pneumococcal vaccination - ✔✔✔<65 years of age without
chronic medical condition
no vaccination needed
Increased risk for pneumococcal vaccination - ✔✔✔>19 and <65 years of
age immunocompetent
Cigarette smokers or chronic conditions
(DM, COPD, CV disease, liver, kidney)
Should receive PPSV23 and repeat after 5 years
Highest risk for pneumococcal vaccination - ✔✔✔>65 years of age or
immunocompromised
>65 receive PCV13 followed by PPSV23 1 year later
Younger patients PCV13 followed by PPSV23 8 in weeks
HIV diagnoses patients and pneumococcal vaccination considerations -
✔✔✔100 times more at risk
receive vaccination as soon as possible
PCV13 followed by PPSV23 8 wks later
Second PPSV23 after 5 years, third dose after 65 y.o.
®™ pg. 3
